Bank of Montreal Can raised its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 21.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 54,458 shares of the company’s stock after buying an additional 9,572 shares during the period. Bank of Montreal Can’s holdings in Phibro Animal Health Corporation were worth $2,018,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock worth $48,597,000 after buying an additional 130,935 shares in the last quarter. Sit Investment Associates Inc. acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth $2,037,000. Seizert Capital Partners LLC acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth $1,518,000. Acadian Asset Management LLC acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth $1,309,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Phibro Animal Health Corporation by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock worth $11,128,000 after buying an additional 43,260 shares in the last quarter. Institutional investors and hedge funds own 47.41% of the company’s stock.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.89% during mid-day trading on Friday, hitting $39.65. The company’s stock had a trading volume of 163,576 shares. Phibro Animal Health Corporation has a 1-year low of $20.14 and a 1-year high of $39.95. The stock has a market cap of $1.57 billion, a PE ratio of 24.63 and a beta of 1.35. The company has a 50-day moving average price of $38.03 and a 200-day moving average price of $32.23.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s payout ratio is 24.69%.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/13/phibro-animal-health-corporation-nasdaqpahc-shares-bought-by-bank-of-montreal-can.html.

PAHC has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Thursday, May 11th. BidaskClub upgraded Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Piper Jaffray Companies set a $35.00 target price on Phibro Animal Health Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, Credit Suisse Group downgraded Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $29.00 to $36.00 in a research note on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $30.50.

In related news, insider Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock in a transaction dated Thursday, May 25th. The stock was sold at an average price of $34.67, for a total transaction of $1,664,160.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Bfi Co., Llc sold 16,000 shares of Phibro Animal Health Corporation stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $36.00, for a total value of $576,000.00. Following the transaction, the insider now owns 28,000 shares of the company’s stock, valued at approximately $1,008,000. The disclosure for this sale can be found here. Insiders sold a total of 352,000 shares of company stock valued at $12,599,200 in the last 90 days. 48.09% of the stock is owned by corporate insiders.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.